- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02459782
Ultrasound Guided Peribulbar Anaesthesia - A Novel Dual Quadrant Injection Technique
May 28, 2015 updated by: Sunnybrook Health Sciences Centre
Ultrasound Guided Peribulbar Anaesthesia: a Real-time Ultrasound Guided Technique With a Novel Dual Quadrant Injection
Peribulbar anaesthesia for ocular surgery depends on the spread of local anaesthetic throught the orbit to be successful and has a relatively high failure rate.
This study will examine a novel ultrasound guided approach to peribulbar anaesthesia which should extend the depostion of local anaesthetic by using a dual quadrant injection technique.
The study will assess the feasibility of this technique, how successful it is and whether any obvious safety issues arise with its use.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Peribulbar anesthesia is widely used for anterior and posterior chamber ophthalmic procedures.
It is a blind technique which is traditionally carried out by inserting a needle in the infero-lateral aspect of the orbit below the globe and injecting a volume of 8 - 12 mL of local anesthetic in the periorbital space.
The goal of this inejction is to achieve akinesia and anesthesia of the eye sufficient for surgery.
The technique has a relatively high failure rate of up to 30%.
A failure or insufficient block requires a second or rarely a third peribulbar injection to achieve success.
Ultrasound can be used to guide needles in the human body and has been successfully used in many anatomic locations for anaesthesia.
This study will assess whether ultrasound can guide the block needle in ophthalmic anesthesia to deliver local anesthetic via a single entry into two discrete locations within the periorbital space - the first in the infero-lateral quadrant and the second in the infero-medial quadrant.
If this can be done the investigators may achieve a higher success rate for this block with a lower volume potentially improving the quality of the block and its safety.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 88 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA score less than III and ability to provide a written informed consent
- 22 patients presenting for opthalmic surgery
Exclusion Criteria:
- Coagulation disorder or anticoagulated with INR > 1.5
- Platelet count < 75 X 10*9/L
- Significant Myopia (axial length > 28mm)
- Patients unable to lie supine for 2 hours
- Patients with recent gas or silicone injections in/around the eye
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: US Guided Dual Quadrant Peribulbar block
Ultrasound guided Dual Quadrant Peribulbar Anaesthesia
|
Landmark Guided single injection vs Ultrasound guided dual quadrant injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Block Success
Time Frame: 10 minutes post intervention
|
Block will be deemed a failure if a supplementary block is required for the operative procedure
|
10 minutes post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Block Quality (standardized Ocular Scoring System for akinesia and anaesthesia)
Time Frame: 5 and 10 minutes
|
Block will be assessed according to a standardized Ocular Scoring System for akinesia and anaesthesia at 5 minutes and 10 minutes post block.
This is a composite measure
|
5 and 10 minutes
|
Block Volume
Time Frame: 1 minute
|
Total volume of local anaesthetic will be recorded.
Volume for each part of the dual injection technique will also be recorded.
This is a composite measure.
|
1 minute
|
Duration of Procedure
Time Frame: 1 to 10 minutes
|
The duration of the entire procedure will be recorded
|
1 to 10 minutes
|
Complications
Time Frame: 6 Weeks
|
Any complications during the procedure or in follow up clinical visits will be recorded
|
6 Weeks
|
Image Visualization
Time Frame: 1 minute
|
Operator's ability to see the needle in both the infero-lateral and infero-medial injection will be recorded.
Ability to see perineural, retrobulbar and medial rectus spread of local anaesthetic will be recorded.
This is a composite qualitative measure.
|
1 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Paul G McHardy, MD, Sunnybrook Health Sciences Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
March 20, 2015
First Submitted That Met QC Criteria
May 28, 2015
First Posted (Estimate)
June 2, 2015
Study Record Updates
Last Update Posted (Estimate)
June 2, 2015
Last Update Submitted That Met QC Criteria
May 28, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 424-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Diseases
-
University of Alabama at BirminghamPfizerCompletedVision | Eye Disease | Eye CareUnited States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
TBF Genie TissulaireCompletedEnucleated; Eye | Eye CancerFrance
-
National Eye Institute (NEI)RecruitingInherited Eye DiseaseUnited States, United Kingdom, China, Pakistan, Philippines, Ukraine, India, Italy
-
National Eye Institute (NEI)Recruiting
-
National Eye Institute (NEI)RecruitingGenetic Eye DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
OptovueCompletedNo Eye DiseaseUnited States, United Kingdom
-
National Eye Institute (NEI)CompletedHereditary Eye DiseaseUnited States
Clinical Trials on Ultrasound guided Dual Quadrant Peribulbar Anaesthesia
-
Sunnybrook Health Sciences CentreUnknownPatients With Difficult Vascular Access.
-
University Health Network, TorontoThe Physicians' Services Incorporated Foundation; Canadian Anesthesiologists...CompletedPatients Undergoing Hand SurgeryCanada
-
Guangdong Provincial People's HospitalCompleted
-
Cork University HospitalCompleted
-
Alexandria UniversityCompleted
-
University Health Network, TorontoCompleted
-
Mahmoud Mohammed AlseoudyUnknownInguinal Hernia | PediatricEgypt
-
Amal Ibrahim MubarakUnknown
-
Mansoura UniversityCompletedElective Major Abdominal SurgeryEgypt